Need professional-grade analysis? Visit stockanalysis.com
$8,958
N/A
N/A
N/A
Cognetivity Neurosciences Ltd (CGNSF) trades on United States in USD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at $0.00.
Over the past year, CGNSF has traded between a low of $0.00 and a high of $0.00. It is currently 94.7% below its 52-week high.
Cognetivity Neurosciences Ltd has a market capitalization of $8,958.
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Side-by-side comparison against top Healthcare peers.